PureTech Health (OTCMKTS:PTCHF – Get Free Report) is expected to be releasing its resultson Thursday, August 27th. Analysts expect the company to announce earnings of ($0.1160) per share and revenue of $24.80 million for the quarter.
PureTech Health Stock Performance
OTCMKTS PTCHF opened at $1.56 on Tuesday. The business has a 50 day simple moving average of $1.61 and a two-hundred day simple moving average of $1.66. PureTech Health has a 1-year low of $1.53 and a 1-year high of $1.92.
About PureTech Health
PureTech Health PLC (“PureTech”) is a clinical-stage biopharmaceutical company focused on the development of innovative medicines to address serious diseases with high unmet medical need. Founded in 2005 by Daphne Zohar and headquartered in Boston, Massachusetts with operations in both North America and Europe, PureTech applies its proprietary platforms to advance therapeutic candidates across immunology, neuroscience and lymphatic-focused indications.
The company leverages three core technology platforms—immune tolerance, gut-targeted delivery and lymphatic transport—to develop novel molecules designed for enhanced specificity and durability of effect.
Read More
- Five stocks we like better than PureTech Health
- Visa Just Put Hims & Hers in the Penalty Box—Here’s Why It Matters
- Treasury Yields Are Surging Again: 3 Stocks That Could Feel the Pain
- Snowflake Could Be Headed for New Highs Despite Insider Selling
- MongoDB Is Surging—And the Next Catalyst Is Almost Here
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
